Month: October 2018
Old Style Muscle Building
Back in the late 1960’s a German named Gert F Koelbel, invented an exercise device called the Tensolator which later on was renamed the Bullworker. This device was based on using the principles of Isometrics or Static Contraction.
Bullworker sales took off like a turbo charged skyrocket, reaching sales of 4 million by the middle of the 1980’s.
What’s remarkable about this is that they never used T.V. advertising. The Bullworker was mostly sold from ads in comic books, some wrestling and bodybuilding magazines.
The Greatest
Even the “Greatest” Muhammad Ali used the exerciser and became one of their spokes model. Our current Governor of California Arnold “The Terminator” Schwarzenegger also used and modeled for the Bullworker. As well as Bruce Lee and a host of other celiberties of it’s day.
Olympic Hope
In addition the German Olympic Power Lifting team of that time trained with the Bullworker and some feel that the incredible results and medals they achieved was mostly due to their Bullworker training. But, The most visible proponent of the Bullworker was actually Bruce Lee who at that time was a weight-training fanatic, until he injured his body doing an exercise called “Good Mornings.”
Warning Will Robinson
If you don’t know what a “good morning” is, let me describe the movement. Take a barbell and place it behind your neck and then bend forward from the waist to till your head is at approximately waist high.
Today no one should do that exercise since it has been recognized as a very dangerous exercise. So, why haven’t you heard of this muscle building miracle?
Steroids And Isometrics
Well, even thou Bob Hoffman and many of the U.S. Olympic Power lifting were using the principles of Isometrics and achieved many wins. Isometrics fell into disfavor. This is fairly common in the fitness community. It seems we’re always on to the next fad or novelty. Today Isometrics, which is one of the few training methods that actually was backed by science (Muller, Hettinger Isometric Studies) has made a resurgence and so has the Bullworker.
Better Than Ever
Since the patent for the product ran out years ago and a resurgence perhaps due to baby boomers a new “hybrid” Bullworker has recently emerged. It’s called the Bully Xtreme Home Gym and it offers all the features of the old Bullworkers and then some.
Of course there has been much more learned regarding the proper way to build muscle mass, so their training program has been totally redesigned, including adding the knowledge and expertise of an NPC Nationals Champion and NPC Judge.
Because over 29 different exercises can be done in a seated position this has made the Bully Xtreme a very popular home gym for people that are incapable due to injury, disability or distance to finally get a an incredible muscle building workout in their home. In fact anyone any age can use this portable home gym and besides it’s a piece of history.
Incredible as it seems this exerciser gets the job done
Samsung is the leading player in the field of mobile handsets. They are aggressive in their approach and want to deliver value for money. The Company is always delivering the best to their esteemed customers.
Samsung mobiles have launched a whole new series of mobile phones with high-tech features and proper battery back-up. Some of the latest Samsung mobiles have touch-screen facility also. Earlier only high-end mobiles had this touch screen facility, but now days, this facility is available in mid-segment mobiles also.
The Company has shown tremendous increase in the sales also. There is virtually no other Company which has revised the prices so much. All the Samsung mobiles are available at much lower cost as compared to their counterparts.
Samsung has introduced Guru as entry level mobile. This is unique in its way that it doesnt need to be recharged frequently. The mobiles USP has gained applauses for the handset and created a huge demand for the mobile phone. The Companys strategy to keep the price as low has led to better sales.
Why revision in prices?
The Company introduced a new policy of volume sales amongst its prime strategies. The volume sales can only be achieved through price revisions. This strategy has worked wonders for the Company and its products.
Capturing major market-share?
This is one of the most sought-after strategies to revise product-prices and capture market-share. When a Company revises its product-prices, then the major motive is to capture major market-share by lowering down prices and alluring customers. The price revision policy has led to better features at lesser prices.
Samsung has captured major market-share with this single policy. The products are heavily advertised and high-end features are introduced at much lower price.
samsung mobiles have created a market-niche with the help of its products price-revision. This strategy of price-revision has worked wonders for the group and led to the success of mobiles in this industry. No other Company could adapt to such measures for them. They have lagged behind in sales as well as market-share.
Samsung mobiles are the most sought-after and most talked-over mobile phones in their segment. Most customers compare their choice of product with Samsung mobile to opt for better one, as per them.
E-Cigarettes: A Brief Timeline
Electronic cigarettes are basically a new phenomenon in the United States, and a lot of people (including smokers) still have not heard about them. But they have been around for years in other parts of the world.
Here is a brief timeline of the electronic cigarette (e-cig for short):
2003 – Beijing based SBT Co. registered a patent for the first e-cig.
2004 – Ruyan, another Beijing company, is now the head; they merged with SBT Co to become SBT Ruyan Technology & Development Co.
oMay 2004: Ruyan sells its first cigarette in China; sales for 2004 total 1.7 million US dollars.
2005 – Sales reach 17 million US dollars
2006 – Sales reach 37 million US dollars
oApril 2006: Ruyan introduces the e-cig in Europe
July 2009 – The FDA releases a warning against electronic cigarettes and states that they may be unfairly marketed to young people.
January 2010 – A federal judge stops the FDA from blocking e-cigs coming into the country from China.
February 2010 – FDA files an appeal of Judge Leon’s ruling.
March 2010 – US Court of Appeals overturns Judge Leon’s ruling, giving the FDA the power to ban e-cig imports.
I wanted to share this information because a lot of people might be interested in e-cigs, but dont want to try something completely new, fearing that it hasnt been properly tested or might be unsafe. But as you can see, the e-cig has been manufactured, tested, and distributed long before its arrival here in the United States.
Hope this helps any of you who are sitting on the fence wondering if you should give them a try.
In 2009, the global anti-hypertensive market was estimated to be worth $27.2 billion, representing a Compound Annual Growth Rate (CAGR) of 5.0% between 2002 and 2009. The market is forecast to reach $30 billion by 2016, indicating a CAGR of 1.5% between 2009 and 2016. The primary reason for slight and gradual growth in the market is the patent expiries of major blockbusters, which are expected to decrease the annual cost of therapy after 2007.
For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Antihypertensives-Market-to-2016-Generic-Erosion-Following-Patent-Expiry-of-Major-ARBs-to-Impact-the-Market&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report
The global anti-hypertensive market is expected to witness a series of patent expiries between 2007 and 2015, which includes most of the top selling blockbuster drugs in the anti-hypertensive market. The major drugs that are set to lose patent protection include Novartiss Diovan (2012), Sanofi Aventiss Avapro (2012), Novartiss Exforge (2012), Takeda/AstraZenecas Blopress/Atacand (2012), Pfizers Revatio (2012), Actelions Tracleer (2015), and United Therapeutics Remodulin (2014). All these drugs together accounted for more than $19.4 billion in revenues in 2009. Mercks Cozaar patent expired in April 2010. The sales of Cozaar for the year 2009 were $3.6 billion. Pfizers Norvasc, which was once the worlds most prescribed drug for hypertension and angina, saw a sales decline of 12% in 2009 due to genericization in 2007. Thus, the series of upcoming patent expiries in the hypertension as well as PAH markets are set to lead to a decline in the market in the near future. However, due to increased usage of fixed dose-combinations and the entry of generics, the market is expected to rise slightly after 2015.
The current anti-hypertensive pipeline does offer some promising novel products, such as SPP635, Actos, LCZ696, QT1571, ACT-293987, PS-433540, Macitentan and Riociguat, indicated for the treatment of hypertension and PAH. However, the revenues generated from these products are not expected to completely make up for the revenue losses due to patent expiries. Thus, the overall global anti-hypertensive market is expected to show flat growth during the forecast period.
GBI Research, a leading business intelligence provider, has released its latest research Antihypertensives Market to 2016 – Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global antihypertensive market. The report analyzes the markets for antihypertensive disorders in the US, the top five markets in Europe (the UK, Germany, France, Italy and Spain), and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Antihypertensives-Market-to-2016-Generic-Erosion-Following-Patent-Expiry-of-Major-ARBs-to-Impact-the-Market&ReportType=Industry_Report&Title=Pharmaceuticals_and_Healthcare
Visit our report store: http://www.gbiresearch.com
For more details contact:
[emailprotected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
Lap tapping is a unique guitar technique whereby the acoustic guitarist holds the instrument flat on his lap while tapping the guitar body and strings percussively while playing the melody.
A small number of technically gifted acoustic guitarists have helped develop this form of guitar playing over the years. Talented guitarists such as Ben Konstantinovic, Tony Haven and Ben Howard have very individual styles and can be seen in action on You Tube. Perhaps the best known of all is Canadian guitarist Erik Mongrain whose songs like Airtap! has enjoyed widespread coverage and racked up millions of views on You Tube. Erik Mongrain uses a unique two handed flat guitar technique which simultaneously combines percussive tapping of the guitar body and chords.
Another up and coming lap tapping guitarist is singer, songwriter Liam Iliffe from Bournemouth, UK. Liam is only 15 years old but has been playing guitar for over 8 years. Although his two handed technique is similar to Erik Mongrain, a key difference is that he tends to favour simpler melodies in his own songs given he also sings at the same time. Liam uses lap tapping primarily as a way to inject more raw emotion and drama into his acoustic compositions.
In 2012, Liam entered Live and Unsigned the UKs biggest talent competition for unsigned artists. After sailing through the auditions, Liam impressed at the Regional finals in Portsmouth and was voted through to the Southern England area finals in May 2012. He was also selected by the Live and Unsigned judges to showcase his lap tapping guitar playing at the Southampton Music festival that will be held in October 2012.
The Live and Unsigned competition also coincides with the launch of Liams debut Album Slap tapping, now available on iTunes, Amazon, Spotify and other major online distributors. Alongside his original songs like Our Bridge and Intervention, the album also features his unusual cover versions of Sweet Dreams by the Eurythmics and the dubstep classic Scary Monsters and Nice Sprites by Skrillex.
Tapping usually incorporates pull-offs or hammer-ons as well, where the fingers of the right hand and, in the motion of removing that finger, pluck the same string already fretted at the eighth fret by the little finger of his/her left hand. It is an extended technique, executed by using one hand to ‘tap’ the strings against the fingerboard, thus producing legato notes. Tapping may be performed either one-handed or two-handed.